©The Author(s) 2025.
World J Diabetes. Oct 15, 2025; 16(10): 110631
Published online Oct 15, 2025. doi: 10.4239/wjd.v16.i10.110631
Published online Oct 15, 2025. doi: 10.4239/wjd.v16.i10.110631
Figure 2 Platelet-rich plasma promotes the proliferation of various cells under high-glucose conditions.
A: Viability of human umbilical vein endothelial cells; B: Human dermal fibroblasts; C: Human immortalized keratinocytes. Significant differences in experimental data were analyzed using t tests, and all assays were performed in triplicate. bP < 0.01 vs the control (CTRL); cP < 0.001 vs CTRL group. PRP: Platelet-rich plasma; CTRL: The control group.
- Citation: Huang C, Liu HZ, Liang JB, Zhao W, Wang YS, Ruan LF, Zhuang WZ, Li YS, Wang Q, Tang YK. In vitro and clinical evaluation of platelet-rich plasma combined with angioplasty in diabetic foot treatment. World J Diabetes 2025; 16(10): 110631
- URL: https://www.wjgnet.com/1948-9358/full/v16/i10/110631.htm
- DOI: https://dx.doi.org/10.4239/wjd.v16.i10.110631